ArticleScientific reports2025
miRNA centered regulatory networks identify FN1 and miR27b as metastatic drivers in HPV negative head and neck cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
The metastasis of human papilloma virus (HPV)-negative head and neck squamous cell carcinoma (HNSC) is associated with poor prognosis, yet the regulatory mechanisms remain unclear. In this study, we developed a metastasis prediction model using the transcriptomes of 333 HPV-negative HNSC tumor samples, representing one of the largest HPV-negative HNSC sample sets to date. Our model, which leverages miRNA-centered regulatory networks extended by regulome data, showed superior predictive performance with an AUC of 0.805 compared to existing metastasis-related biomarkers. We identified three key miRNAs in our model with significant differential expression in metastatic patients. Notably, miR-27b was downregulated and its target gene FN1 was overexpressed, leading to activation of the cell adhesion pathway. Single-cell RNA-seq analysis confirmed FN1 overexpression specifically in the malignant cells of metastasis patients with HPV-negative HNSC. In vitro, miR-27b was found to reduce metastatic potential by negatively regulating FN1 expression at the translational level. These findings suggest FN1, driven by miR-27b, as a potential driver of metastasis in HPV-negative HNSC, offering new avenues for biomarker development and targeted therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.